Linkage between Toll-like receptor (TLR) 2 promotor and intron polymorphisms: functional effects and relevance to

M Veltkamp1, P A H M Wijnen, C H M van Moorsel

  • 1Heart Lung Center Utrecht, Department of Pulmonology, St. Antonius Hospital, Nieuwegein, The Netherlands. veltkamp76@hotmail.com

Insights

Genetic variations in Toll-like receptor (TLR) 2 may influence sarcoidosis development and cytokine patterns in a subset of patients. Further research is needed to confirm these findings and understand their functional impact.

Area of Science:

  • Immunology
  • Genetics
  • Pulmonology

Background:

  • Sarcoidosis is a systemic inflammatory disease characterized by granuloma formation.
  • Propionibacterium acnes and Mycobacterium tuberculosis are suspected etiological agents.
  • Toll-like receptor (TLR) 2 plays a crucial role in the immune response to these pathogens.

Purpose of the Study:

  • To investigate the association between TLR-2 gene polymorphisms and sarcoidosis.
  • To explore the functional consequences of TLR-2 variations on cytokine production.

Main Methods:

  • Genotyping of TLR-2 polymorphisms (single nucleotide and dinucleotide repeat) in 419 sarcoidosis patients and 196 controls.
  • Analysis of genotype-phenotype correlations, including disease chronicity.
  • In vitro stimulation of peripheral blood mononuclear cells (PMBCs) with TLR-2 agonists to assess cytokine induction (TNF-alpha, IL-12, IL-6).

Main Results:

  • A specific TLR-2 genotype (AA at -16934) was associated with chronic sarcoidosis in the study cohort, but not confirmed in the validation cohort.
  • Linkage disequilibrium was observed between the TLR-2 promotor polymorphism -16934 A/T and GT repeats in intron 1.
  • GT repeat number correlated with the induction of TNF-alpha, IL-12, and IL-6 in response to TLR-2 agonists.

Conclusions:

  • TLR-2 gene polymorphisms may contribute to sarcoidosis in a small patient subgroup.
  • Functional consequences of these polymorphisms partially explain variations in cytokine profiles across different sarcoidosis clinical phenotypes.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon has three reading...